Related Experiment Video
Updated: Jan 25, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition
Zhou Yang1, Dejun Wu1, Yusheng Chen1
1Department of General Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center , Shanghai , China.
Abstract:
Our previous study has demonstrated that knockdown of Grainyhead-like 2(GRHL2) in colorectal cancer (CRC) cells inhibited cell proliferation by targeting ZEB1. This study aimed at researching whether knockdown of GRHL2 promoted CRC progression and metastasis via inducing epithelial-mesenchymal transition (EMT). GRHL2-upregulated SW-620/GRHL2+ and GRHL2-knockdown HCT116/GRHL2-KD, HT29/GRHL2-KD cells and their control cells were generated. The morphological changes after overexpression and knockdown GRHL2 were observed. qRT-PCR, Western blotting, and Immunofluorescence were used to detect EMT markers: E-cadherin, Vimentin, p-catein, ZO-1 and ZEB1 expression. Then, sh-ZEB1 was transfected to GRHL2 knockdown cells to research the relationship between GRHL2 and ZEB1. Transwell and wound healing assays were further performed to detect the impact of GRHL2 on invasion and migration in vitro. CRC cells were injected into mice tail vein to verify the impact of GRHL2 on CRC metastasis. Morphological change of mesenchymal-epithelial transition (MET) could be observed in SW620/GRHL2+ cell. The expression of epithelial markers: E-cadherin, β-catenin, ZO-1 were up-regulated, while mesenchymal markers: Vimentin was decreased. Meanwhile, opposite EMT morphological change could be observed in HCT116/GRHL2-KD cell, accompanied by reverse change of E-cadherin, β-catenin, ZO-1, and Vimentin. The expression level of GRHL2 and ZEB1 was found negative in both SW620/GRHL2+ and HCT116/GRHL2-KD cells. Knockdown of ZEB1 by siRNA in HCT116/GRHL2-KD and HT29/GRHL2-KD could upregulate expression of E-cadherin and GRHL2. GRHL2 knockdown also promoted migration, invasion in vitro and CRC metastasis in mice model. In conclusion, GRHL2/ZEB1 axis inhibits CRC progression and metastasis via oppressing EMT.
Insights
Grainyhead-like 2 (GRHL2) and ZEB1 suppress colorectal cancer (CRC) progression and metastasis by inhibiting epithelial-mesenchymal transition (EMT). GRHL2 knockdown promotes CRC cell migration, invasion, and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Colorectal cancer (CRC) progression is linked to epithelial-mesenchymal transition (EMT).
- Grainyhead-like 2 (GRHL2) has been previously shown to inhibit CRC cell proliferation by targeting ZEB1.
Purpose of the Study:
- To investigate the role of GRHL2 in promoting CRC progression and metastasis via EMT.
- To elucidate the relationship between GRHL2 and ZEB1 in regulating CRC cell behavior.
Main Methods:
- Generation of GRHL2-overexpressing and GRHL2-knockdown CRC cell lines.
- Analysis of EMT markers (E-cadherin, Vimentin, β-catenin, ZO-1, ZEB1) using qRT-PCR, Western blotting, and immunofluorescence.
- In vitro assays (Transwell, wound healing) and in vivo mouse tail vein injection model to assess migration, invasion, and metastasis.
Main Results:
- GRHL2 overexpression induced mesenchymal-epithelial transition (MET) with increased epithelial markers and decreased mesenchymal markers.
- GRHL2 knockdown promoted EMT, increasing migration, invasion, and metastasis in vitro and in vivo.
- GRHL2 and ZEB1 expression were inversely correlated; ZEB1 knockdown partially rescued the effects of GRHL2 knockdown.
Conclusions:
- The GRHL2/ZEB1 axis plays a crucial role in inhibiting CRC progression and metastasis.
- Suppressing EMT through the GRHL2/ZEB1 pathway represents a potential therapeutic strategy for colorectal cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Phase Transitions
Feedback Inhibition
Properties of Transition Metals
Cooperative Allosteric Transitions
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

